Abacavir in Combination With the Inosine Monophosphate Dehydrogenase (IMPDH)–Inhibitor Mycophenolic Acid Is Active Against Multidrug-Resistant HIV-1
- 1 December 1999
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 22 (4), 406
- https://doi.org/10.1097/00042560-199912010-00013
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Transmission of antiretroviral-drug-resistant HIV-1 variantsThe Lancet, 1999
- Abacavir and Mycophenolic Acid, an Inhibitor of Inosine Monophosphate Dehydrogenase, Have Profound and Synergistic Anti-HIV ActivityJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic In VitroAntimicrobial Agents and Chemotherapy, 1998
- Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89Antimicrobial Agents and Chemotherapy, 1997
- Polymerase Substrate Depletion: A Novel Strategy for Inhibiting the Replication of the Human Immunodeficiency VirusVirology, 1995
- Mechanisms of Action of Mycophenolic AcidAnnals of the New York Academy of Sciences, 1993
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989